Literature DB >> 6094463

Epidemiology of enterobacteria resistant to cefotaxime in hospital.

C H Tancrede, A O Andremont, F C Leonard.   

Abstract

Cefotaxime treatment eliminates normally susceptible strains of enterobacteria from the digestive tract, and increases intestinal carriage of resistant enterobacteria in individuals. However the global rate of such carriage remains low in hospitalized patients and resistant strains are exceptionally isolated from bacteraemia in spite of an intensive use of this antibiotic. The epidemiology of resistant strains of enterobacteria has to be carefully monitored. The results obtained by the control of faecal carriage shows that this technique is a means of surveying evolution in this area.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6094463     DOI： 10.1093/jac/14.suppl_b.53

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  5 in total

1.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

2.  Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacae.

Authors:  M H Nicolas; N Honore; V Jarlier; A Philippon; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 3.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

4.  Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit.

Authors:  C De Champs; M P Sauvant; C Chanal; D Sirot; N Gazuy; R Malhuret; J C Baguet; J Sirot
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance.

Authors:  H K van Saene; C P Stoutenbeek; D F Zandstra
Journal:  Drugs       Date:  1988       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.